Lung Cancer Resource Center

Feature articles

New Consensus on Approach to Molecular Testing in Lung Cancer

New Consensus on Approach to Molecular Testing in Lung Cancer

New guidelines provide direction on molecular testing for patients who could benefit from targeted lung cancer treatment.

Prognosis is Poorer in Patients with Lung Cancer Who Are HIV-Infected

Prognosis is Poorer in Patients with Lung Cancer Who Are HIV-Infected

Even when accounting for competing risks, data shows that patients with lung cancer who are HIV-infected have a worse prognosis than those who are noninfected.

ALK Inhibitors and Non-Small Cell Lung Cancer: A Promising Advance in Targeted Therapy

ALK Inhibitors and Non-Small Cell Lung Cancer: A Promising Advance in Targeted Therapy

For the subset of patients with non-small cell lung cancer who are ALK-positive, targeted therapy offers the potential for improved long-term outcome.

Lung Cancer Resources

More Lung Cancer Information

Cigar Smoking and Cancer

This fact sheets answers common questions patients may have about the link between cigar smoking and cancer.

Lung Cancer: New Tools for Making Decisions About Treatment

This patient fact sheet contains information on the different types of tumors as well as an overview of available biomarker tests and personalized medicine.

The Rising Incidence of Lung Cancer in Women: A Disturbing Trend

The Rising Incidence of Lung Cancer in Women: A Disturbing Trend

While the incidence of lung cancer in males has decreased over the last few decades, the rates of the disease have doubled in women.

A Look into the Pipeline: ALK Inhibitors Under Investigation

A Look into the Pipeline: ALK Inhibitors Under Investigation

In addition to crizotinib, other targeted therapies for NSCLC are currently in development.

Q&A with Mark Socinski, MD, on the POINTBREAK Trial of Maintenance Therapy for NSCLC

Q&A with Mark Socinski, MD, on the POINTBREAK Trial of Maintenance Therapy for NSCLC

Editorial Advisory Board member Dr. Socinski discusses the key clinical insights brought to light by the POINTBREAK trial, presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.

ACS Recommends Lung Cancer Screening with Low-Dose CT

ACS Recommends Lung Cancer Screening with Low-Dose CT

Results of the National Lung Screening Trial have led to new recommendations for individuals at high risk for lung cancer.

It's Time to Quit

It's Time to Quit

Cancer patients who smoke are notoriously reluctant to give up the habit, but a cancer diagnosis may present a unique educational moment.

Abraxane® Injectable Suspension (paclitaxel protein-bound particles) (albumin-bound)

Abraxane® Injectable Suspension (paclitaxel protein-bound particles) (albumin-bound)

This slideshow reviews Abraxane® Injectable Suspension (paclitaxel protein-bound particles (albumin-bound) for patients with non-small cell lung cancer.

Table of Contents

Slide 3: ...

Advanced NSCLC: Best Treatment Option

Advanced NSCLC: Best Treatment Option

By Sandra Cuellar, PharmD, BCOP

A 63-year-old male is referred by his primary care physician for work-up of possible lung cancer. ...

A Rare Cause of Intestinal Dysmotility in a Patient with Small Cell Lung Cancer

A Rare Cause of Intestinal Dysmotility in a Patient with Small Cell Lung Cancer

By Tara Morrison, MD; Yu-Ning Wong, MD, MSCE

A 66-year-old African American man presented with a several month history of weight ...

Lung Cancer

Lung Cancer

More people in the United States die from lung cancer than any other type of cancer. This is true for ...

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs